EASTAMPTON, N.J., Jan. 10, 2014 (GLOBE NEWSWIRE) -- Epicore BioNetworks Inc. ("Epicore") (TSX-V:EBN) announced today that in connection with its Normal Course Issuer Bid conducted through the facilities of the TSX Venture Exchange that the Member conducting the Normal Course Issuer Bid has been changed from Macquarie Private Wealth to Richardson GMP Limited due to the acquisition of the former by the latter.
For details of the Normal Course Issuer Bid readers are referred to the Company news release dated August 29, 2013, and filed on the SEDAR website, www.sedar.com.
Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity. Epicore is a major supplier to the shrimp aquaculture industry.
Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). [Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.]
CONTACT: Mr. William P. Long Chief Executive Officer USA Tel: (609) 267 9118 Email: Investors@EpicoreBioNetworks.com
Source:Epicore BioNetworks Inc.